The Efficacy of Gabapentin and Pregabalin in the Treatment of Neuropathic Pain due to Peripheral Nerve Injury

REFERENCES

• Merskey H, Bogduk N: Classification of chronic pain: Description of chronic pain syndromes and definition of pain terms. IASP Press, Seattle, 1994, 40–43.
   Google Scholar
• Jensen TS, Gottrup H, Sindrup SH, Bach FW: The clinical picture of neuropathic pain. European Journal of Pharmacology 429(1–3): 1–11, 2001.
   PubMed Web of Science ®Google Scholar
• Curran N: Chronic pain following trauma. Trauma 7: 123–131, 2005.
   Google Scholar
• Koltzenburg M, Scadding J. Neuropathic pain. Current Opinion in Neurology 14(5): 641–647, 2001
   PubMed Web of Science ®Google Scholar
• Rollin M, Gallagher RP: Early, continuous, and restorative pain management in injured soldiers: The challenge ahead. Pain Medicine 7(4): 284–286, 2006.
   PubMed Web of Science ®Google Scholar
• Wiffen P, McQuay H, Edwards J, Moore RA: Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews (3): CD005452, 2005.
   Google Scholar
• Freeman R, Durso-Decruz E, Emir B: Efficacy, safety and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy; findings from seven randomized controlled trials across a range of doses. Diabetes Care 31(7): 1448–1454, 2008.
   PubMed Web of Science ®Google Scholar
• Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS: Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Medicine 2(7): e164, 2005.
   Web of Science ®Google Scholar
• Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG: Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Archives of Physical Medicine and Rehabilitation 88(12): 1547–1560, 2007.
   PubMed Web of Science ®Google Scholar
• Vranken JH, Dijkgraaf MG, Kruis MR, Van der Vegt MH, Hollmann MW, Heesen M: Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 136(1–2): 150–157, 2008.
   PubMed Web of Science ®Google Scholar
• Gordh TE, Stubhaug A, Jensen TS, Arner S, Biber B, Boivie J, Mannheimer C, Kalliomaki J, Kalso E. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 138(2): 255–266, 2008.
   PubMed Web of Science ®Google Scholar
• Bennett M: The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 92(1–2): 147–157, 2001.
   PubMed Web of Science ®Google Scholar
• Vernon MK, Brandenburg NA, Alvir JM, Griesing T, Revicki DA: Reliability, validity, and responsiveness of the Daily Sleep Interference Scale among diabetic peripheral neuropathy and postherpetic neuralgia patients. Journal of Pain and Symptom Management 36(1): 54–68, 2008.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM: Advances in neuropathic pain. Diagnosis, mechanisms, and treatment recommendations. Archives of Neurology 60(11): 1524–1534, 2003.
   PubMed Web of Science ®Google Scholar
• Rice AS, Hill RG. New treatment for neuropathic pain. Annual Review of Medicine 57: 535–551, 2006.
   PubMed Web of Science ®Google Scholar
• Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews (3): CD005454, 2005.
   Google Scholar
• Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews (3): CD001133, 2005.
   Google Scholar
• Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Science of the United States of America 103(46): 17537–17542, 2006.
   PubMed Web of Science ®Google Scholar
• Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: The calcium channel alpha2-delta subunit as a target for antiepileptic drug discovery. Epilepsy Research 73(2): 137–150, 2007.
   PubMed Web of Science ®Google Scholar
• Meyer-Rosberg K, Kvarnström A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain – A multidimensional burden for patients. European Journal of Pain 5(4): 379–389, 2001.
   PubMed Web of Science ®Google Scholar
• Rice AS, Maton S. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 94(2): 215–224, 2001.
   PubMed Web of Science ®Google Scholar
• Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 280(21): 1831–1836, 1998.
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280(21): 1837–1842, 1998.
   PubMed Web of Science ®Google Scholar
• Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 63(11): 2104–2110, 2004.
   PubMed Web of Science ®Google Scholar
• Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. Journal of Pain 6(4): 253–260, 2005.
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 110(3): 628–638, 2004.
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115(3): 254–263, 2005.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young JP , Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 60(8): 1274–1283, 2003.
   PubMed Web of Science ®Google Scholar
• Sabatowski R, Gálvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, Versavel M; 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 109(1–2): 26–35, 2004.
   PubMed Web of Science ®Google Scholar
• Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: Review and implications. Neurology 68(15): 1178–1182, 2007.
   PubMed Web of Science ®Google Scholar
• O'Connor AB. Neuropathic pain. Quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 27(2): 95–112, 2009.
   PubMed Web of Science ®Google Scholar
• Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: What is the effect of pain reduction? Anesthesia and Analgesia 102(5): 1473–1479, 2006.
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Haanpää M, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P: EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology 13(11): 1153–1169, 2006.
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine 352(13): 1324–1334, 2005.
   PubMed Web of Science ®Google Scholar
• Bennett MI, Smith BH, Torrance N, Lee AJ: Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 122(3): 289–294, 2006.
   PubMed Web of Science ®Google Scholar
• Solak O, Metin M, Esme H, Solak O, Yaman M, Pekcolaklar A, Gurses A, Kavuncu V: Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain. European Journal of Cardiothoracic Surgery 32(1): 9–12, 2007.
   PubMed Web of Science ®Google Scholar
• Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC: Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. Journal of Neurology, Neurosurgery & Psychiatry 76(6): 833–838, 2005.
   PubMed Web of Science ®Google Scholar
• Hans G, Joukes E, Verhulst J, Vercauteren M: Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: Study of 40 consecutive cases. Current Medical Research & Opinion 25(11): 2737–2743, 2009.
   PubMed Web of Science ®Google Scholar